Skip to main content

Accessibility Tools

Article

Comparator Drugs play a key role in trials. Sourcing the right drug in the right quantity, at the right time, and reliably can be complicated. Not with us.

Two important components for successful comparator drug sourcing are 1) accessibility and 2) reliability – getting the drugs you need and ensuring supply continuity throughout your trial.

We have all experienced the fragility of supply chains. During the peak of the COVID-19 Pandemic, there were economic impacts, protective measures, and import/export bans limiting access to some drugs on the world market. Natural disasters such as tornadoes like the one that impacted a North Carolina Pfizer plant in 2023, flash floods, and hurricanes can stop production or destroy entire factories further disrupting supply chains. Or manufacturing problems that led to the shortage of the cancer drugs Cisplatin and Carboplatin. After a FDA inspection of a facility in India that did not go well, additional checks, a slow batch release and the stop of manufacturing led to a global shortage.

Shortages become a bigger problem – even after the pandemic phase of Covid is over. It is critical to have a partner who is aware of shortages, understands the challenges of drug sourcing and has forged strategic, time-tested ties with manufacturers to find alternatives.

For over 35 years, Myonex has specialized in sourcing comparator drugs bolstered by our trusted relationships with various reliable suppliers. Myonex’s dedicated sourcing and procurement teams in the US and Europe work to ensure no disruption in the drug supply for your trials. Our team of experts continuously monitors global markets to identify potential drug shortages to craft timely and effective strategies so you can focus on what matters most – patient outcomes throughout your trial.
“Our dedicated sourcing and procurement teams are constantly monitoring markets globally to identify alternative sources and strategies for products that are under a shortage.”, says Matt Grace, Vice President Clinical Trial Drug Sourcing at Myonex, “This includes the options of potentially utilizing EU product for clinical trials in the US where Myonex can manage the import of these products into the US under an Investigational New Drug Application (IND) and label and distribute these products direct to sites from our facility in Horsham, PA.”

Shortages become a bigger problem – even after the pandemic phase of Covid is over. It is critical to have a partner who is aware of shortages, understands the challenges of drug sourcing and has forged strategic, time-tested ties with manufacturers to find alternatives.

Accessibility and reliability, getting the drugs you need, and ensuring supply continuity throughout your trial, are two important components of a successful clinical trial. Myonex’s experience allows us to be faster, more flexible, and reliable in your drug-sourcing options.